Comment
doi: 10.1016/S0140-6736(15)60017-4.
Pathological complete response in breast cancer
Affiliations
- PMID: 25706465
- DOI: 10.1016/S0140-6736(15)60017-4
Item in Clipboard
Comment
Pathological complete response in breast cancer
Lancet.
.
No abstract available
Comment in
-
Pathological complete response in breast cancer--authors' reply.Lancet. 2015 Jan 10;385(9963):114-5. doi: 10.1016/S0140-6736(15)60018-6. Lancet. 2015. PMID: 25706464 No abstract available.
Comment on
-
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.Lancet. 2014 Jul 12;384(9938):164-72. doi: 10.1016/S0140-6736(13)62422-8. Epub 2014 Feb 14. Lancet. 2014. PMID: 24529560 Review.
Similar articles
-
Pathological complete response in breast cancer.Lancet. 2015 Jan 10;385(9963):113. doi: 10.1016/S0140-6736(15)60015-0. Lancet. 2015. PMID: 25706463 No abstract available.
-
Pathological complete response in breast cancer.Lancet. 2015 Jan 10;385(9963):113. doi: 10.1016/S0140-6736(15)60016-2. Lancet. 2015. PMID: 25706462 No abstract available.
-
Pathological complete response in breast cancer--authors' reply.Lancet. 2015 Jan 10;385(9963):114-5. doi: 10.1016/S0140-6736(15)60018-6. Lancet. 2015. PMID: 25706464 No abstract available.
-
Pathological assessment of sentinel lymph-node biopsies in patients with breast cancer.Virchows Arch. 2000 Feb;436(2):97-101. doi: 10.1007/pl00008220. Virchows Arch. 2000. PMID: 10755597 Review. No abstract available.
-
Ductal intraepithelial neoplasia of the breast.Virchows Arch. 2001 Mar;438(3):221-7. doi: 10.1007/s004280100394. Virchows Arch. 2001. PMID: 11315617 Review. No abstract available.
Cited by
-
¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.Eur J Nucl Med Mol Imaging. 2016 May;43(5):983-993. doi: 10.1007/s00259-015-3295-z. Epub 2016 Jan 13. Eur J Nucl Med Mol Imaging. 2016. PMID: 26758726 Review.
-
The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future.Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2695-2700. doi: 10.1007/s00259-024-06758-y. Eur J Nucl Med Mol Imaging. 2024. PMID: 38735885 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
